Metagenomi Therapeutics MGX
NASDAQ MGX
$1.12 -0.01 (-0.89%)
As of: Sep 30, 2026 · 12:38 PM EDT

Metagenomi Therapeutics, Inc. (MGX) Common Equity (2023 - 2026)

Updated

Metagenomi Therapeutics' Common Equity came in at $112.57 million for Q2 2026, down 42.5% from $195.83 million a year earlier and down 18.3% from the prior quarter.

Analysis

Metagenomi Therapeutics, Inc. (MGX) Common Equity (2023 - 2026) Analysis & Trends

At the end of FY2025, Metagenomi Therapeutics' Common Equity was $158.6 million, down 32.5% from FY2024.

  • Going back by year, Common Equity was $234.86 million in FY2024 and -$135.58 million in FY2023.
  • The Q2 2026 figure represents the lowest quarterly Common Equity since Q4 2023.
  • Year-over-year, Common Equity has declined for six consecutive quarters, with an average decline of 31.8% over the last six quarters.
  • Business Quant data shows MGX's Common Equity at $137.79 million (Q1 2026), $158.6 million (Q4 2025) and $178.45 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 112.57 Mn
Mar 31, 2026 137.79 Mn
Dec 31, 2025 158.60 Mn
Sep 30, 2025 178.45 Mn
Jun 30, 2025 195.83 Mn
Mar 31, 2025 212.66 Mn
Dec 31, 2024 234.86 Mn
Sep 30, 2024 255.77 Mn
Jun 30, 2024 269.42 Mn
Mar 31, 2024 275.63 Mn
Dec 31, 2023 -135.58 Mn
Sep 30, 2023 -119,021.00
Jun 30, 2023 -102.54 Mn
Mar 31, 2023 -90.01 Mn
API Access

Metagenomi Therapeutics, Inc. Common Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=common-equity&ticker=MGX&period=max&api_key=YOUR_API_KEY